https://t.co/F8W6TfGxWq
What are food grade recombinant proteins and what makes #LaurusBio exciting? 👇🏼
Making Maruti 800s for an industry where only Ferraris are available 🚙

More from Tar ⚡
To see the bull case for #IEX one needs a bit of imagination on their side :)
Market always moves to the cheaper alternative, slowly at first, then all of a sudden.
Market always moves to the cheaper alternative, slowly at first, then all of a sudden.
As more and more companies look towards the ESG factors, IEX would be a potential beneficiary.
— Kharanshu Parikh (@Kharanshu) August 7, 2021
Source: Suven Pharma\u2019s Annual Report
\u2066@itsTarH\u2069 pic.twitter.com/sRdMIAMaVP
More from Lauruslabs
Laurus Labs - Double top buy will be activated above closing of 690. Target still active: 895 (1%*3 box size and reversal)
✅✅ https://t.co/MtJOLfpzYj
✅✅ https://t.co/MtJOLfpzYj

Laurus Labs - I am waiting till 3:15 PM to get confirmation of closing above 700 to add more of it in my portfolio. \u2705\u2705 pic.twitter.com/UxZCuxhuIX
— Steve Nison (@nison_steve) August 9, 2021
And just to clarify before people start posting
"Rocket Emojis with to the moon tags"
this business wouldn't hit 3lk cr market cap in next 3 yrs but it can steadily compound at 25-30% YoY for next 10 yrs
At 25% CAGR over 10 yrs, you get a 10 bagger
Keep expectations in check.
"Rocket Emojis with to the moon tags"
this business wouldn't hit 3lk cr market cap in next 3 yrs but it can steadily compound at 25-30% YoY for next 10 yrs
At 25% CAGR over 10 yrs, you get a 10 bagger
Keep expectations in check.
Lets talk results #lauruslabs
— Tar \u26a1 (@itsTarH) July 29, 2021
Always zoom out and view the results, never take a QoQ approach.
Here is how Sales, Op.Profit and PAT looks like when you zoom out.
The upwards trends continues.
No business will move linearly up or linearly down. pic.twitter.com/O9UUt1rEE5